AKT Inhibition Mitigates GRP78 (glucose-regulated Protein) Expression and Contribution to Chemoresistance in Endometrial Cancers

Overview

Journal Int J Cancer

Specialty Oncology

Date 2013 Jan 3

PMID 23280503

Citations 26

Authors

Michael J Gray

Paulette Mhawech-Fauceglia

EunJeong Yoo

Wangrong Yang

Eijean Wu

Amy S Lee

Yvonne G Lin

Affiliations

Soon will be listed here.

Abstract

Overexpression of the unfolded protein response master regulator GRP78 is associated with poor prognosis and therapeutic resistance in numerous human cancers, yet its role in endometrial cancers (EC) is undefined. To better understand the contribution of GRP78 to EC, we examined its expression levels in EC patient samples and EC cell lines. We demonstrate that GRP78 overexpression occurs more frequently in EC tissues compared with that found in normal endometrium, and that GRP78 expression occurs in most EC cell lines examined. Functional analysis demonstrated that GRP78 is inducible by cisplatin in EC cells, and siRNA knockdown of GRP78 augments chemotherapy-mediated cell death. Examination of AKT and GRP78 expression demonstrated that inhibition of AKT activity by MK2206 blocks GRP78 expression in EC cells. SiRNA studies also revealed that knockdown of GRP78 reduces but does not abrogate AKT activity, demonstrating that GRP78 is required for optimal AKT activity. In the presence of MK2206, siRNA knockdown of GRP78 does not augment AKT mediated survival in response to cisplatin treatment, suggesting that GRP78's antiapoptosis functions are part of the AKT survival pathway. Targeted therapies that reduce GRP78 expression or activity in cancers may serve to increase the effectiveness of current therapies for EC patients.

Citing Articles

HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells.

Chen Z, Tang X, Li W, Li T, Huang J, Jiang Y Transl Oncol. 2024; 46:102017.

PMID: 38852277 PMC: 11193040. DOI: 10.1016/j.tranon.2024.102017.

GRP78 Activity Moderation as a Therapeutic Treatment against Obesity.

Pan D, Yang Y, Nong A, Tang Z, Li Q Int J Environ Res Public Health. 2022; 19(23).

PMID: 36498048 PMC: 9739731. DOI: 10.3390/ijerph192315965.

LncRNA LINC00534 regulates cell proliferation and migration via the miR-494-3p/PTEN axis in HTR-8/SVneo cells.

Song X, Zhang X, Xia Q, Li C, Zhang Y, Huang Y J Clin Lab Anal. 2022; 37(1):e24802.

PMID: 36478207 PMC: 9833967. DOI: 10.1002/jcla.24802.

Heat Shock Proteins: Potential Modulators and Candidate Biomarkers of Peripartum Cardiomyopathy.

Chakafana G, Spracklen T, Kamuli S, Zininga T, Shonhai A, Ntusi N Front Cardiovasc Med. 2021; 8:633013.

PMID: 34222357 PMC: 8241919. DOI: 10.3389/fcvm.2021.633013.

Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism.

Conza D, Mirra P, Cali G, Insabato L, Fiory F, Beguinot F Cells. 2021; 10(5).

PMID: 33946426 PMC: 8147131. DOI: 10.3390/cells10051067.

References

Dai R, Chen S, Yan D, Chen R, Lui Y, Duan C . PI3K/Akt promotes GRP78 accumulation and inhibits endoplasmic reticulum stress-induced apoptosis in HEK293 cells. Folia Biol (Praha). 2010; 56(2):37-46. View

Fu Y, Wey S, Wang M, Ye R, Liao C, Roy-Burman P . Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci U S A. 2008; 105(49):19444-9. PMC: 2614780. DOI: 10.1073/pnas.0807691105. View

Reddy R, Mao C, Baumeister P, Austin R, Kaufman R, Lee A . Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem. 2003; 278(23):20915-24. DOI: 10.1074/jbc.M212328200. View

Misra U, Pizzo S . Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells. Cancer Biol Ther. 2010; 9(2):142-52. DOI: 10.4161/cbt.9.2.10422. View

Wright J, Barrena Medel N, Sehouli J, Fujiwara K, Herzog T . Contemporary management of endometrial cancer. Lancet. 2012; 379(9823):1352-60. DOI: 10.1016/S0140-6736(12)60442-5. View

Chappell W, Steelman L, Long J, Kempf R, Abrams S, Franklin R . Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget. 2011; 2(3):135-64. PMC: 3260807. DOI: 10.18632/oncotarget.240. View

Fu Y, Li J, Lee A . GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007; 67(8):3734-40. DOI: 10.1158/0008-5472.CAN-06-4594. View

Luo B, Lee A . The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene. 2012; 32(7):805-18. PMC: 3819728. DOI: 10.1038/onc.2012.130. View

Dong D, Stapleton C, Luo B, Xiong S, Ye W, Zhang Y . A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res. 2011; 71(8):2848-57. PMC: 3078191. DOI: 10.1158/0008-5472.CAN-10-3151. View

10.

Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S . Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res. 2001; 7(4):892-5. View

11.

Xing X, Li Y, Liu H, Wang L, Sun L . Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis. Acta Histochem. 2010; 113(8):777-82. DOI: 10.1016/j.acthis.2010.11.006. View

12.

Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y . Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res. 2000; 60(21):5988-94. View

13.

Gonzalez-Gronow M, Selim M, Papalas J, Pizzo S . GRP78: a multifunctional receptor on the cell surface. Antioxid Redox Signal. 2009; 11(9):2299-306. DOI: 10.1089/ARS.2009.2568. View

14.

Hoekstra A, Ward E, Hardt J, Lurain J, Singh D, Buttin B . Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecol Oncol. 2008; 108(3):609-18. DOI: 10.1016/j.ygyno.2007.11.007. View

15.

Kelber J, Panopoulos A, Shani G, Booker E, Belmonte J, Vale W . Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 2009; 28(24):2324-36. PMC: 2749668. DOI: 10.1038/onc.2009.97. View

16.

Belyanskaya L, Hopkins-Donaldson S, Kurtz S, Simoes-Wust A, Yousefi S, Simon H . Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int J Cancer. 2005; 117(5):755-63. DOI: 10.1002/ijc.21242. View

17.

Chen T . GRP78/BiP modulation of GRP78/BiP in altering sensitivity to chemotherapy. Methods Enzymol. 2011; 491:25-36. DOI: 10.1016/B978-0-12-385928-0.00002-X. View

18.

Jiang L, Zhang L, Wang Q, Wang S . [Down-regulation of GRP78 Enhances Chemotherapy Sensitivity to VP-16 in Lung Adenocarcinoma.]. Zhongguo Fei Ai Za Zhi. 2010; 12(11):1159-63. DOI: 10.3779/j.issn.1009-3419.2009.11.06. View

19.

Gonzalez-Gronow M, Cuchacovich M, Llanos C, Urzua C, Gawdi G, Pizzo S . Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res. 2006; 66(23):11424-31. DOI: 10.1158/0008-5472.CAN-06-1721. View

20.

Wendel H, de Stanchina E, Fridman J, Malina A, Ray S, Kogan S . Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004; 428(6980):332-7. DOI: 10.1038/nature02369. View